

Journey Group should benefit from the economic recovery and the knock-on effect on airlines, Midas said in the Mail on Sunday. The company, which is b...


LONDON (Alliance News) - GW Pharmaceuticals PLC said Monday that it has continued to make progress with its cannabinoid pipeline, as it provided an up...


LONDON (Alliance News) - Shares are gaining at the open Tuesday on a strong lead in from Asia and ahead of UK industrial production data at 0930.Foxto...






LONDON (Alliance News) - GW Pharmaceuticals PLC Friday said the US Food and Drug Administration has granted its Epidiolex epilepsy treatment orphan dr...


Investors fail to appreciate the long-term potential in shares of interdealer broker Icap. This may be somewhat understandable due to the changing nat...


* UniQure has Western world's first approved gene therapy * Sells shares at $17 each vs $13-15 indicated range By Ben Hirschler Feb 5 (Reuters) - A sm...